custom image

Obesity: From Cell to Patient

February 1-3, 2020 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change

Obesity is a chronic disease affecting millions of people world-wide, and is often associated with numerous co-morbidities, including Type II diabetes, liver disease and cardiovascular disease. This conference aims to gather the world leaders in obesity research and discuss numerous topics- from the cell to the patient- as they relate to obesity. Obesity is an annual topic for Keystone Symposia and is considered to be one of the most critical in the field and the previous Keystone Symposia conferences have been heavily focused on basic research. Therefore, this conference program particularly aims to address this gap by providing a greater balance with clinical/translational research on the program. Additionally, there are sessions that have a special focus on the gut/brain axis, including the microbiota, as there is emerging research in this area that has made transformational steps in our understanding of etiology of this disease, as well as in treatment. Moreover, there is strong evidence that the gut/brain axis is important not just for appetitive behavior but also energy homeostasis, blood glucose and even emotional state. Finally, this conference is being held jointly with the annual diabetes conference, Diabetes: Many Faces of the Disease, as there is obvious overlap in these fields. Therefore, the program will contain joint sessions and even a joint Keynote speaker. With this pairing, it is anticipated to draw the leaders in this field from around the world, as well as the next generation of future scientists. Connecting scientists in basic, transitional, clinical and pharmaceutical research will be crucial to moving the field forward.


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission
for Short Talk Consideration:
 December 17, 2020
ePoster Abstract Submission: January 19, 2021
Financial Aid Application: January 19, 2021


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here! 

Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.

Program Details

Keynote Speaker

Anthony S. Fauci, MD

Morris F. White

Boston Children's Hospital, Harvard Medical School, USA

Peripheral and Central Faces of Hepatic Insulin Resistance

Speaking at this eSymposia

Rachel L. Batterham

University College London, UK

Hans Rudolf Berthoud

Pennington Biomedical Research Center, USA

Diego V. Bohórquez

Duke University Medical Center, USA

Michael A. Cowley

Monash University, Australia

Ana Domingos

University of Oxford, UK

Carmella Evans-Molina

Indiana University, USA

Stephanie E. Fulton

University of Montreal, Canada

Carla J. Greenbaum

Benaroya Research Institute at Virginia Mason, USA

Sean M. Hartig

Baylor College of Medicine, USA

Shane T. Hentges

Colorado State University, USA

Alka M. Kanaya

University of California, San Francisco, USA

Lotte Bjerre Knudsen

Novo Nordisk A/S, Denmark

Michael Krashes

NIDDK, National Institutes of Health, USA

Rory J. McCrimmon

University of Dundee, UK

Martin G. Myers Jr.

University of Michigan, USA

Max Nieuwdorp

University of Amsterdam, Netherlands

Mary-Elizabeth Patti

Joslin Diabetes Center, USA

Shirly Pinto

Kallyope, USA

Linda Rinaman

Florida State University, USA

Darleen A. Sandoval

University of Colorado, USA

Camilla Charlotte Schéele

University of Copenhagen, Denmark

Philipp E. Scherer

University of Texas Southwestern Medical Center, USA

Gary J. Schwartz

Albert Einstein College of Medicine, USA

Michael W. Schwartz

University of Washington, USA

Dana M. Small

Yale University School of Medicine, USA

Elinor L. Sullivan

Oregon National Primate Research Center, USA

Roy Taylor

Newcastle University, UK

Murielle M. Veniant

Amgen Inc., USA

Stephanie Wesolowski

University of Colorado Denver, USA

Morris F. White

Boston Children's Hospital, Harvard Medical School, USA

Lori M. Zeltser

Columbia University, USA

More program details will be available soon.

Subscribe to receive updates to the program for this meeting.

Email address:    

Editors Attending This Meeting [UPDATE]

custom image

Teodoro-Pulvirenti, PhD 

Executive Editor, Journal of Experimental Medicine (JEM)

custom image

Gaia Trincucci, PhD 

Scientific Editor, Journal of Experimental Medicine (JEM)

custom image

Céline Carret, PhD

Scientific Editor, EMBO Molecular Medicine

custom image

Zeljko Durdevic, PhD

Scientific Editor, EMBO Molecular Medicine

custom image

Denise Doolan, PhD

Specialty Chief Editor, Frontiers in Immunology

custom image

Alessandra Fornarelli, Dr. rer. nat.

Journal Manager, Frontiers in Immunology



Additional Support


Funding for this conference was made possible (in part) by Grant No. 1 R13 DK127724-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Tags: eSymposia